View up-to-date information on Mirati Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
WO2022192507A1 | Application | CRYSTALLINE SALT OF A MULTI-TYROSINE KINASE INHIBITOR, METHOD OF PREPARATION, AND USE THEREOF | C07B2200/13; C07D495/04 | September 15, 2022 |
WO2022192745A1 | Application | MTA-COOPERATIVE PRMT5 INHIBITORS | A61P31/00; A61P43/00; C07D401/10; C07D401/14; C07D403/10; C07D405/14; C07D409/14; C07D413/14; C07D471/04; C07D495/04 | September 15, 2022 |
US20220274990A1 | Application | IMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES AS PRC2 INHIBITORS FOR TREATING CANCER | C07D487/04 | September 01, 2022 |
EP4043466A1 | Application | PRC2-INHIBITOREN | A61K31/519; A61P35/00; C07D487/04 | August 17, 2022 |
EP3880208A4 | Search Report | KRAS-G12C-INHIBITOREN | A61K31/519; A61K31/5355; A61K31/5377; A61P35/00; C07D471/04; C07D491/08 | August 17, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer